TransMedics TMDX
NASDAQ TMDX
$93.04 -0.93 (-0.99%)
At close: Aug 20, 2026 · 1:16 PM UTC

TransMedics (TMDX) Other Operating Expenses (2023)

TransMedics (TMDX) posted quarterly Other Operating Expenses of $27.2 million for Q3 2023.

TransMedics (TMDX) Other Operating Expenses (2023) Analysis & Trends

TransMedics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at $27.2 million for Q3 2023.

  • In Q3 2023, Other Operating Expenses changed N/A year-over-year to $27.2 million; the TTM figure through Jun 2024 stood at $27.2 million (changed N/A YoY), while the FY2023 annual figure was $27.2 million, changed N/A from the prior year.
  • Other Operating Expenses for Q3 2023 stood at $27.2 million.
  • The five-year high for Other Operating Expenses was $27.2 million in Q3 2023, with the low at $27.2 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn
10 TransMedics 3.22 Bn 2.74 Bn 113.20 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 27.21 Mn